Home Newsletters Human Immunology News CECR2 Drives Breast Cancer Metastasis by Promoting NF-κB Signaling and Macrophage-Mediated Immune...

CECR2 Drives Breast Cancer Metastasis by Promoting NF-κB Signaling and Macrophage-Mediated Immune Suppression

0
Investigators found that distant metastases were more immune inert with increased M2 macrophages compared to their matched primary tumors.
[Science Translational Medicine]

Sorry, but the selected Zotpress account can't be found.

Full Article
Exit mobile version